Harry and Blake take a deep dive into the City of Denver giving a license/permit to MedPharm to cultivate, process, manufacture, and transfer marijuana to other labs for research purposes. Although, Denver has been legal since 2012 it has taken until 2020 to get research and development underway. This is the last piece in the licensing puzzle for the company’s study on how cannabis-based medication might impact Alzheimer’s disease and other forms of dementia. Over the course of the six-month study, which will launch once all 30 patients are enrolled, MedPharm will monitor whether the patients’ symptoms are improving—whether they’re sleeping better, eating better or feeling less agitated. Watch the complete interview with Harry and Blake.